![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1532578
Á¤ÀÚÀºÇà ½ÃÀå : ¼ºñ½º À¯Çüº°, ±âÁõÀÚº°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(2024-2032³â)Sperm Bank Market, By Service Type (Sperm Storage, Semen Analysis, Genetic Consultation), By Donor (Known, Anonymous, ID Disclosure), By Technique (Donor Insemination, IVF), By End-use (Hospitals, Clinics, Fertility Centers) - Forecast (2024 - 2032) |
Á¤ÀÚÀºÇà ½ÃÀå ±Ô¸ð´Â 2024-2032³â CAGR 3.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
WHO¿¡ µû¸£¸é Àü ¼¼°è ¼ºÀÎ Àα¸ÀÇ ¾à 17.5%, Áï 6¸í Áß 1¸íÀÌ ºÒÀÓÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ºÒÀÓÀº Àü ¼¼°è Àüü ºÎºÎÀÇ ¾à 10-15%°¡ °Þ°í ÀÖÀ¸¸ç, Ãâ»ê Áö¿¬, »ýȰ½À°ü º¯È, ȯ°æÀû ¿µÇâ, °Ç° »óÅ µîÀÇ ¿äÀÎÀÌ ºÒÀÓÀÇ ¿øÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó º¸Á¶»ý½Ä¼ú(ART) ¹× ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¤ÀÚ ±âÁõ, º¸Á¸, À¯Àü »ó´ã µîÀÇ ¼ºñ½º ÀÌ¿ëÀÌ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
°ÈµÈ ³Ãµ¿ º¸Á¸ ±â¼úÀº Á¤ÀÚÀºÇà »ê¾÷¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Á¤ÀÚ »ùÇÃÀÇ º¸Á¸°ú º¸°üÀÌ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀü¿¡´Â ¾óÀ½ °áÁ¤ÀÇ Çü¼ºÀ» ÃÖ¼ÒÈÇÏ°í µ¿°á °úÁ¤¿¡¼ ¼¼Æ÷ ¼Õ»óÀ» ÁÙÀÌ´Â À¯¸®È ¹æ¹ýÀÇ °³¹ßÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ µ¿°á º¸È£Á¦ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀº Á¤ÀÚ ¼¼Æ÷¸¦ ´õ Àß º¸È£Çϰí ÇØµ¿½Ã »ýÁ¸À²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÚµ¿ÈµÈ ³Ãµ¿ ¹× ÇØµ¿ ½Ã½ºÅÛµµ ³Î¸® º¸±ÞµÇ¾î ÀϰüµÇ°í ÃÖÀûÀÇ º¸Á¸ Á¶°ÇÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº º¸Á¸µÈ Á¤ÀÚÀÇ Ç°Áú°ú ¿îµ¿¼ºÀ» ´õ ³ô°Ô À¯ÁöÇÔÀ¸·Î½á º¸Á¶»ý½Ä¼ú(ART)ÀÇ ¼º°ø·üÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.
Á¤ÀÚÀºÇà »ê¾÷Àº ¼ºñ½º À¯Çü, ±âÁõÀÚ, ±â¼ú, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.
À¯Àü »ó´ã ºÐ¾ß´Â 2032³â±îÁö ±Þ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù. ÀÌ ¼ºñ½º´Â À¯Àü¼º ÁúȯÀÇ Àڳ࿡°Ô À¯ÀüµÇ´Â °ÍÀ» °ÆÁ¤ÇÏ´Â °³Àΰú ºÎºÎ¿¡°Ô ¸Å¿ì Áß¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. Á¾ÇÕÀûÀÎ À¯ÀüÀÚ °Ë»ç ¹× »ó´ãÀ» Á¦°øÇÔÀ¸·Î½á Á¤ÀÚÀºÇàÀº °í°´ÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î °áÁ¤À» ³»¸®°í ÁÁÀº À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏÀ» °¡Áø ±âÁõÀÚ¸¦ ¼±ÅÃÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ´Â ART ¼ö¼úÀÇ ¾ÈÀü¼º°ú ¼º°ø·üÀ» ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó, »ý½Ä ÀÇ·á ºÐ¾ß¿¡¼ ¸ÂÃãÇü ÀÇ·á¿Í Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ºÎ¹®Àº Á¤ÀÚÀºÇà°ú Çù·ÂÇÏ¿© Á¤ÀÚ Á¦°ø, Àڱó» Àΰø¼öÁ¤(IUI), ü¿Ü¼öÁ¤(IVF), À¯ÀüÀÚ °Ë»ç µî ´Ù¾çÇÑ ¼ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ 2032³â±îÁö ºü¸¥ ¼Óµµ·Î È®ÀåµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Á¤ÀÚÀºÇà°ú ºÒÀÓŬ¸®´ÐÀÇ ÆÄÆ®³Ê½ÊÀ» ÅëÇØ °í°´Àº ù »ó´ãºÎÅÍ Àӽмº°ø±îÁö Á¾ÇÕÀûÀÎ °ü¸®¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. Ŭ¸®´ÐÀº Á¤ÀÚÀºÇàÀÇ ±âÁõÀÚ ¸ðÁý, ¼±º° ¹× º¸Á¸¿¡ ´ëÇÑ Àü¹® Áö½ÄÀ» Ȱ¿ëÇÏ¿© ȯÀÚ¿¡°Ô ¾çÁúÀÇ ºÒÀÓ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. Àü ¼¼°è¿¡¼ ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÷´Ü ÀÎÇÁ¶ó¿Í ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡°¡ ½ÃÀå Àü¸ÁÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
À¯·´ÀÇ Á¤ÀÚÀºÇà »ê¾÷Àº ¿ìÈ£ÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ART ½Ã¼ú¿¡ ´ëÇÑ ³ôÀº ¼ö¿ë¼º, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿¡ ÈûÀÔ¾î 2032³â±îÁö ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹, µ§¸¶Å©, ½ºÆäÀΰú °°Àº ±¹°¡µéÀÌ ÃÖ÷´Ü ºÒÀÓ Ä¡·á ¼ºñ½º¸¦ Á¦°øÇϰí Áö¿ª ¾ÈÆÆ¿¡¼ °í°´À» À¯Ä¡ÇÏ´Â µ¥ ¾ÕÀå¼°í ÀÖÀ¸¸ç, ARTÀÇ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í »ç¿ë °¡´ÉÇÑ Ä¡·á¹ýÀÇ ÆøÀ» ³ÐÈ÷±â À§ÇÑ ¼ö¸¹Àº ÀÓ»ó ¿¬±¸ ¹× ÀÓ»ó½ÃÇè°ú °°Àº ¿¬±¸°³¹ß¿¡ ´ëÇÑ °·ÂÇÑ ÃÊÁ¡Àº ¾÷°èÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù.
The Sperm Bank Market size will exhibit 3.8% CAGR during 2024-2032, driven by the rising prevalence of infertility. According to WHO, approximately 17.5% of the adult population, or roughly 1 in 6 individuals worldwide, experience infertility. Infertility affects approximately 10-15% of couples globally, with factors such as delayed parenthood, lifestyle changes, environmental influences, and health conditions contributing to the incidence. This has led to a heightened demand for assisted reproductive technologies (ART) and fertility treatments. Increased utilization of services, including sperm donation, preservation, and genetic consultation is stimulating the market growth.
Enhanced cryopreservation techniques are revolutionizing the sperm bank industry, leading to improved preservation and storage of sperm samples. These advancements include the development of vitrification methods, which minimize ice crystal formation and reduce cellular damage during the freezing process. Additionally, innovations in cryoprotectant solutions are providing better protection for sperm cells, enhancing their viability upon thawing. Automated freezing and thawing systems are also becoming more prevalent, ensuring consistent and optimal preservation conditions. These improvements are significantly increasing the success rates of assisted reproductive technologies (ART) by maintaining higher quality and motility of preserved sperm.
The sperm bank industry is classified based on service type, donor, technique, end-use and region.
The genetic consultation segment will grow rapidly through 2032, as this service is crucial for individuals and couples who are concerned about passing on genetic disorders to their children. By providing comprehensive genetic screening and counseling, sperm banks can help clients make informed decisions and choose donors with favorable genetic profiles. This not only enhances the safety and success rates of ART procedures but also addresses the growing demand for personalized and precision medicine in reproductive health.
Clinics segment will expand at a fast pace through 2032, as they collaborate with sperm banks to offer a range of services, including sperm donation, intrauterine insemination (IUI), in vitro fertilization (IVF), and genetic screening. The partnership between sperm banks and fertility clinics ensures that clients receive comprehensive care, from initial consultation to successful conception. Clinics leverage the expertise of sperm banks in donor recruitment, screening, and preservation to provide high-quality fertility solutions to their patients. The increasing number of fertility clinics worldwide, coupled with their advanced infrastructure and skilled healthcare professionals, is favoring the market outlook.
Europe sperm bank industry will grow at a steady pace through 2032, driven by supportive regulatory frameworks, high acceptance of ART procedures, and advanced healthcare infrastructure. Countries such as the United Kingdom, Denmark, and Spain are at the forefront, offering state-of-the-art fertility services and attracting clients from across the region and beyond. A strong emphasis on R&D, with numerous clinical studies and trials aimed at improving ART outcomes and expanding the range of available treatments, will bolster the industry growth.